Revenue
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Qiagen N.v. (QGEN)
Price$43.47Cached quote
Net income
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.09B | $1.98B | $1.97B | $2.14B | $2.25B | $1.87B | $1.53B | $1.50B | $1.42B | $1.34B | $1.28B | $1.34B | $1.30B | $1.25B | $1.17B | $1.09B | $1.01B | $893.0M |
| Gross profit | $1.30B | $967.4M | $1.23B | $1.38B | $1.45B | $1.23B | $1.01B | $1.00B | $922.6M | $844.7M | $826.7M | $865.2M | $815.5M | $824.0M | $749.8M | $715.6M | $667.1M | $599.7M |
| Gross margin | 62.18% | 48.90% | 62.77% | 64.65% | 64.43% | 65.91% | 65.86% | 66.65% | 65.08% | 63.13% | 64.53% | 64.34% | 62.63% | 65.69% | 64.10% | 65.80% | 66.06% | 67.16% |
| Research & development | $187.5M | $193.5M | $198.5M | $189.9M | $190.0M | $149.1M | $157.4M | $161.9M | $154.1M | $149.8M | $146.8M | $163.7M | $146.1M | $122.5M | $130.6M | $126.0M | $107.9M | $97.3M |
| Operating expenses | $833.6M | $869.6M | $823.8M | $853.1M | $820.7M | $846.3M | $1.03B | $734.4M | $769.1M | $745.8M | $647.2M | $703.5M | $752.2M | $654.2M | $650.2M | $527.0M | $486.9M | $454.0M |
| Operating income | $465.9M | $97.7M | $409.9M | $531.5M | $630.1M | $386.4M | −$26.1M | $266.6M | $153.4M | $98.8M | $179.5M | $161.7M | $63.3M | $169.8M | $99.6M | $188.5M | $180.2M | $145.7M |
| Operating margin | 22.29% | 4.94% | 20.86% | 24.82% | 27.98% | 20.66% | −1.71% | 17.75% | 10.82% | 7.39% | 14.01% | 12.02% | 4.86% | 13.54% | 8.51% | 17.34% | 17.85% | 16.31% |
| EBITDA | $659.6M | $301.0M | $615.3M | $739.9M | $845.0M | $591.4M | $205.3M | $473.0M | $369.9M | $311.9M | $371.0M | $362.5M | $262.7M | $367.7M | $267.0M | $331.3M | $228.8M | $188.3M |
| EBITDA margin | 31.56% | 15.21% | 31.31% | 34.55% | 37.53% | 31.62% | 13.45% | 31.50% | 26.09% | 23.31% | 28.96% | 26.95% | 20.18% | 29.31% | 22.82% | 30.47% | 22.66% | 21.08% |
| Net income | $424.9M | $83.6M | $341.3M | $423.2M | $512.6M | $359.2M | −$41.5M | $190.4M | $40.4M | $80.4M | $130.1M | $116.4M | $69.1M | $129.5M | $96.0M | $144.3M | $137.8M | $89.0M |
| Net profit margin | 20.33% | 4.23% | 17.37% | 19.76% | 22.77% | 19.20% | −2.72% | 12.68% | 2.85% | 6.01% | 10.16% | 8.65% | 5.31% | 10.32% | 8.21% | 13.27% | 13.64% | 9.97% |
| Basic EPSper basic share | $1.96 | $0.38 | $1.50 | $1.86 | $2.25 | $1.57 | -$0.18 | $0.84 | $0.18 | $0.34 | $0.56 | $0.50 | $0.30 | $0.55 | $0.41 | $0.62 | $0.67 | $0.45 |
| Diluted EPSper diluted share | $1.94 | $0.37 | $1.48 | $1.84 | $2.21 | $1.53 | -$0.18 | $0.82 | $0.17 | $0.34 | $0.55 | $0.48 | $0.29 | $0.54 | $0.40 | $0.60 | $0.64 | $0.44 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
WELLINGTON MANAGEMENT GROUP LLP | 12.41M |
PRICE T ROWE ASSOCIATES INC /MD/ | 11.35M |
PRINCIPAL FINANCIAL GROUP INC | 6.65M |
VANGUARD CAPITAL MANAGEMENT LLC | 6.21M |
BlackRock, Inc. | 5.91M |
MORGAN STANLEY | 5.04M |
EARNEST PARTNERS LLC | 4.57M |
GOLDMAN SACHS GROUP INC | 4.44M |
NORGES BANK | 4.33M |
MILLENNIUM MANAGEMENT LLC | 3.85M |
Amundi | 3.68M |
MARSHALL WACE, LLP | 3.49M |
UBS Group AG | 3.42M |
Helikon Investments Ltd | 3.09M |
BANK OF AMERICA CORP /DE/ | 3M |
DIMENSIONAL FUND ADVISORS LP | 2.76M |
Fivespan Partners, LP | 2.69M |
SEI INVESTMENTS CO | 2.35M |
Allspring Global Investments Holdings, LLC | 2.22M |
DEUTSCHE BANK AG\ | 2.19M |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data